The apoptotic insensitivity conferred by PTEN loss may play a role in our breast cancer model system in light of previous results showing that apoptotic resistance does not directly promote tumor growth, but can increase metastasis when combined with activation of the Ras-MEK pathway38. Here, MAP2K7 is linked to breast cancer.